Palivator 9mg Tablet ER
Marketer
Ryon Pharma
Salt Composition
Paliperidone (9mg)
Overview Palivator 9mg Tablet ER
Extended-release Palivator 9mg tablets treat schizophrenia (a debilitating mental illness causing hallucinations, delusions, and impaired thinking and behavior) and manic episodes. Palivator 9mg ER tablets can be taken with or without food, but consistent daily timing ensures stable blood levels. Follow your doctor's prescribed dosage and regimen; if a dose is missed, take it immediately upon recall. Never abruptly discontinue this medication without consulting your physician, as abrupt cessation may exacerbate symptoms. Immediately stop treatment and seek medical help if Neuroleptic malignant syndrome (NMS) occurs (manifested by fever, muscle stiffness, and altered mental status). Common side effects include involuntary eye movements (nystagmus) and tremors. Drowsiness and dizziness are also possible; avoid activities requiring alertness until the medication's effects are known. Increased diabetes risk is associated with this medication; regular glucose monitoring is recommended. Report any unusual mood shifts, new or worsening depression, or suicidal ideation to your doctor immediately.
Uses of Palivator 9mg Tablet ER
Psychosis involving both schizophrenic and manic features
Major Benefits of Palivator 9mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Palivator 9mg Extended-Release Tablets. The tablets should be swallowed whole; do not break, crush, or chew them. While Palivator 9mg ER can be ingested with or without food, consistent timing is recommended for optimal results.
Common Side effects of Palivator 9mg Tablet ER:
- Abnormal involuntary movements
- Dizziness
- Nystagmus (involuntary eye movement)
- Sleepiness
- Tremors
How to use Palivator 9mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The 9mg extended-release Palivator tablet should be swallowed whole; do not crush, chew, or break it. While Palivator 9mg Tablet ER can be administered with or without food, consistent daily timing is recommended.
How Palivator 9mg Tablet ER works:
Extended-release Palivator 9mg tablets are an atypical antipsychotic medication. Their mechanism of action involves modulating dopamine and serotonin neurotransmitter levels to positively impact mood, cognition, and behavior.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Palivator 9mg extended-release tablets and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Extended-release Palivator 9mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Palivator 9mg tablets are likely not safe for use while breastfeeding. Available evidence from humans indicates potential transfer to breast milk with the possibility of infant harm.
DrivingUNSAFE
Extended-release Palivator 9mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Exercise caution when administering Palivator 9mg Extended-Release tablets to individuals with impaired kidney function; dosage modification may be necessary. Physician consultation is advised. Palivator 9mg Extended-Release tablets are contraindicated in patients experiencing end-stage renal disease.
LiverCAUTION
Exercise caution when administering Palivator 9mg Extended-Release tablets to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Data regarding Palivator 9mg Extended-Release tablet use in such patients is limited. Dosage alteration is not advised for those with mild to moderate liver dysfunction.
What if you forget to take Palivator 9mg Tablet ER :
NA
Facts to Know About Palivator 9mg Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Benzisoxazole-based compound |
| Developing Habits | No. |
| Type of Treatment | Neuroscience of the Central Nervous System |
| Action Class | Nontypical Antipsychotics |
3,018 People bought this recently